Elaine C. Johnstone
Department of Clinical Pharmacology
Cancer Research UK Medical Statistics Group
Centre for Statistics in Medicine
University of Oxford
United Kingdom
Name/email consistency: high
- Determinants of the rate of nicotine metabolism and effects on smoking behavior. Johnstone, E., Benowitz, N., Cargill, A., Jacob, R., Hinks, L., Day, I., Murphy, M., Walton, R. Clin. Pharmacol. Ther. (2006)
- Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch. Johnstone, E.C., Yudkin, P.L., Hey, K., Roberts, S.J., Welch, S.J., Murphy, M.F., Griffiths, S.E., Walton, R.T. Pharmacogenetics (2004)
- The dopamine D2 receptor C32806T polymorphism (DRD2 Taq1A RFLP) exhibits no association with smoking behaviour in a healthy UK population. Johnstone, E.C., Yudkin, P., Griffiths, S.E., Fuller, A., Murphy, M., Walton, R. Addict. Biol (2004)
- Zyban for smoking cessation in a general practice setting: the response to an invitation to make a quit attempt. Johnstone, E., Hey, K., Drury, M., Roberts, S., Welch, S., Walton, R., Murphy, M. Addict. Biol (2004)